Sydney, Australia – 22 May, 2019 – Pivotal Systems Corporation (“Pivotal” or the “Company”) (ASX: PVS) today announces the appointment of Dr Thomas Duthy of Nemean Group Pty Ltd (“Nemean”) to lead Pivotal’s investor relations initiatives, effective from 23 May, 2019.
Prior to establishing Nemean in late 2018, Tom was the Global Head of Investor Relations & Corporate Development at Sirtex Medical Limited (ASX:SRX) an S&P/ASX Top 200 Company that was acquired in September 2018 for A$1.9 billion, and to date represents the largest medical device transaction in Australian corporate history. Prior to Sirtex, he spent a decade as a leading sell-side analyst at Taylor Collison Limited in Sydney.
Mr John Hoffman, Chairman and CEO of Pivotal Systems commented, “As our Company grows and the awareness within the Australian financial markets builds, it is vital to have someone on the ground in Australia who possesses significant technical and financial market expertise to engage with our existing investors and analysts, while generating new investor interest through an effective investor relations strategy aligned with our corporate activities and goals, to drive shareholder value.”
– ENDS –
Investor Relations & Media (Australia):
Dr Thomas Duthy
+61 402 493 727
Company Matters Pty Ltd
Media Contact (US):
Pivotal Systems provides the best-in-class gas flow monitoring and control technology platform for the global semiconductor industry. The company’s proprietary hardware and software utilizes advanced machine learning to enable preventative diagnostic capability resulting in an order of magnitude increase in fab productivity and capital efficiency for existing and future technology nodes. Pivotal Systems Corporation (ARBN 626 346 325), is a company incorporated in Delaware, USA, whose stockholders have limited liability.